The antihypertensive compounds hydralazine, dihydralazine and cadralazine and their metabolites inhibit myeloperoxidase activity as measured by chemiluminescence.
Nässberger
L
L
Department of Medical Microbiology, University of Lund, Sweden.
D000959:Antihypertensive Agents / Q000494:pharmacology*; D001665:Binding Sites; D004078:Dihydralazine / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D006830:Hydralazine / Q000494:pharmacology*; D008163:Luminescent Measurements; D009682:Magnetic Resonance Spectroscopy; D009195:Peroxidase / Q000037:antagonists & inhibitors* / Q000302:isolation & purification; D011724:Pyridazines / Q000494:pharmacology*; D013329:Structure-Activity Relationship
D000959:Antihypertensive Agents; D011724:Pyridazines; D006830:Hydralazine; C055809:ISF 2405; C031877:cadralazine; D009195:Peroxidase; D004078:Dihydralazine